Related Experiment Videos
Effect of mevinolin on rat hepatocytes: a morphometric study
P Rebuffat1, A S Belloni, L Cavallini
1Department of Anatomy, University of Padua, Italy.
Experimental Pathology
|January 1, 1988
Summary
Mevinolin, a cholesterol synthesis inhibitor, initially lowered cholesterol in rats. Prolonged use caused liver cell growth and organelle expansion as a compensatory response.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Cholesterol synthesis is a vital metabolic pathway.
- Inhibitors of cholesterol synthesis can impact cellular processes.
- Understanding compensatory mechanisms in the liver is crucial.
Purpose of the Study:
- To investigate the effects of mevinolin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on plasma cholesterol and liver structure in rats.
- To elucidate the cellular and morphological adaptations in the rat liver following prolonged mevinolin treatment.
Main Methods:
- Short-term (12 h) and continuous (7 days) administration of mevinolin to rats.
- Measurement of plasma cholesterol concentrations.
- Histological and ultrastructural analysis of liver tissue, focusing on hepatocytes, endoplasmic reticulum, and peroxisomes.
Main Results:
- Short-term mevinolin infusion significantly reduced plasma cholesterol.
- Continuous treatment led to the disappearance of hypocholesterolemia.
- Hepatocyte volume increased, accompanied by proliferation of rough and smooth endoplasmic reticulum membranes.
- A significant increase in the number of peroxisomes was observed.
Conclusions:
- Prolonged mevinolin treatment induces significant adaptive changes in rat liver morphology.
- Hepatocyte hypertrophy and organelle proliferation are key components of the liver's compensatory response to inhibited cholesterol synthesis.
- These structural alterations represent the morphologic basis for maintaining homeostasis during HMG-CoA reductase inhibition.